Remdesivir use in severe and critical COVID-19 patients might be associated with lower incidence of arterial thrombotic events

INTRODUCTION: Venous thromboembolism (VTE) and arterial thrombotic (AT) events are a striking feature of severe COVID-19, however, relationship of remdesivir use and the risk of thrombotic events is unknown and has not been investigated before. METHODS: We retrospectively analyzed a cohort of 876 co...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucijanic, Marko, Bistrovic, Petra, Jordan, Ana, Mihaljevic, Iva, Bukvic, Stela, Kovacevic, Stjepan, Ranilovic, Darjan, Sakota, Sara, Vlasac Glasnovic, Josipa, Delic-Brkljacic, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170894/
https://www.ncbi.nlm.nih.gov/pubmed/37201450
http://dx.doi.org/10.1016/j.ajem.2023.05.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170894/
https://www.ncbi.nlm.nih.gov/pubmed/37201450
http://dx.doi.org/10.1016/j.ajem.2023.05.007

Ejemplares similares